Ketogenic diet with immunotherapy for advanced skin and kidney cancers
Part of Cancer, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study tests whether a special high-fat, low-carbohydrate diet (ketogenic diet) can be safely combined with immunotherapy drugs to help treat advanced melanoma, squamous cell skin cancer (cSCC), or kidney cancer (RCC). It aims to see if this diet might make the immunotherapy work better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have advanced melanoma, squamous cell skin cancer, or kidney cancer
- You are about to start or are already receiving certain immunotherapy drugs like nivolumab or pembrolizumab
- You are able to follow the ketogenic diet and attend all study visits
- Your blood counts, kidney, and liver function are within acceptable ranges
- You have a body mass index (BMI) between 18 and 35
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a change in diet can help people with early-stage melanoma or lung cancer who are receiving immunotherapy (a type of treatment that helps your immune system fight cancer). You will be asked to follow a diet, give blood and stool samples, and complete questionnaires to see how the diet affects your body and treatment.
This early-phase study tests whether adding immunotherapy (nivolumab and ipilimumab) to prednisone and sirolimus can control advanced skin cancers in people with kidney transplants. It aims to see how well the treatment works and how safe it is for transplant recipients.
This trial tests whether a special prebiotic diet can help your body's bacteria (microbiome) better respond to standard immunotherapy for advanced melanoma that cannot be removed by surgery. If you are starting your first immunotherapy, you may be able to join.
This trial tests whether a special diet low in certain amino acids (building blocks of protein), combined with an immune-boosting antibody drug, can safely shrink stage III melanoma that has spread to lymph nodes. The goal is to see if this combination works better than standard treatment.
This study tests how well immunotherapy drugs like pembrolizumab and nivolumab work for people with advanced melanoma that has spread. It aims to find markers that predict treatment response.
This study tests whether adding high-intensity exercise and a high-fiber diet can improve how well immunotherapy works for people with melanoma. It might help you if you are already on immunotherapy and are not currently very active or eating a lot of fiber.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.